Patents by Inventor Satish K. Pejaver

Satish K. Pejaver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR DELIVERY OF TAXANES IN STABLE OIL-IN-WATER EMULSIONS
    Publication number: 20110166214
    Abstract: The present invention provides methods and compositions for delivery of taxanes in stable oil-in-water emulsion. The inventive emulsion formulation includes an oil phase, aqueous and emulsifier phases. The oil portion includes all or substantial amount of taxane, vegetable oil and medium chain triglycerides; aqueous phase includes an emulsion stabilizer; emulsifier phase reduces the surface tension between oil and aqueous phases to produce a stable oil-in-water emulsion. The inventive compositions produce minimal side effects upon administration.
    Type: Application
    Filed: January 7, 2011
    Publication date: July 7, 2011
    Applicant: INNOPHARMA, LLC
    Inventors: HARI R. DESU, KANAIYALAL R. PATEL, SATISH K. PEJAVER, NAVNEET PURI
  • Esmolol formulation
    Patent number: 6528540
    Abstract: An aqueous, sterile pharmaceutical composition suitable for parenteral administration for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture, are disclosed.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: March 4, 2003
    Assignee: Baxter International Inc.
    Inventors: Jie Liu, Satish K. Pejaver, George Owoo
  • Esmolol formulation
    Publication number: 20020147239
    Abstract: An aqueous, sterile pharmaceutical composition suitable for parenteral administration for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture, are disclosed.
    Type: Application
    Filed: October 30, 2001
    Publication date: October 10, 2002
    Applicant: Baxter International Inc.
    Inventors: Jie Liu, Satish K. Pejaver, George Owoo
  • Ready-to-use esmolol solution
    Patent number: 6310094
    Abstract: A ready-to-use injectable, aqueous pharmaceutical composition for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture in a container, is disclosed.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: October 30, 2001
    Assignee: Baxter International Inc.
    Inventors: Jie Liu, Satish K. Pejaver, George Owoo
  • Propofol formulation with enhanced microbial characteristics
    Patent number: 6100302
    Abstract: Formulations of intravenous anesthetic propofol emulsions are provided which contain sufficiently low concentrations of soybean oil to produce a stable emulsion and simultaneously provide reduced nutrients, which inhibit microbial growth thereby providing protection against accidental microbial contamination during long-term IV infusions. In addition to the inhibition of microbial growth due to a reduction of nutrients, the formulation exhibits unanticipated additional microbial inhibition due to an increased availability of propofol. The low concentration of soybean oil also provides a formulation that reduces the chances of fat overload when administered over an extended period of time to chronically ill patients.
    Type: Grant
    Filed: April 5, 1999
    Date of Patent: August 8, 2000
    Assignee: Baxter International Inc.
    Inventors: Satish K. Pejaver, Rajeshwar Motheram, Barrett E. Rabinow, Josben C. dela Rosa